Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kim, Kyung Eun ^a   Jung, Youngae ^b   Min, Soonki ^b,c   Nam, Miso ^b,c   Heo, Rok Won ^a   Jeon, Byeong Tak ^d   Song, Dae Hyun ^a   Yi, Chin Ok ^a   Jeong, Eun Ae ^a   Kim, Hwajin ^a   Kim, Jeonghyun ^e   Jeong, Seon Yong ^e   Kwak, Woori ^f   Ryu, Do Hyun ^c   Horvath, Tamas L ^g   Roh, Gu Seob ^a,g   Hwang, Geum Sook ^b,h  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^e Ajou University School of Medicine   (South Korea)

^f C and K Genomics ^*  (South Korea)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; KETONE; TRIACYLGLYCEROL;

ANIMAL; BIOSYNTHESIS; BODY WEIGHT; CALORIC RESTRICTION; DIET THERAPY; ENDOPLASMIC RETICULUM STRESS; LIPID METABOLISM; LIPOGENESIS; LIQUID CHROMATOGRAPHY; LIVER; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; MOUSE; NONALCOHOLIC FATTY LIVER; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; BODY WEIGHT; CALORIC RESTRICTION; CHROMATOGRAPHY, LIQUID; COLLAGEN; ENDOPLASMIC RETICULUM STRESS; KETONES; LIPID METABOLISM; LIPOGENESIS; LIVER; MASS SPECTROMETRY; METABOLOMICS; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; TRIGLYCERIDES;

EID: 84979574325     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30111     Document Type: Article

References (55)

1. Black, S. A. Diabetes, diversity, and disparity: what do we do with the evidence? Am J Public Health 92, 543-548 (2002).
2. Gruben, N., Shiri-Sverdlov, R., Koonen, D. P. & Hofker, M. H. Nonalcoholic fatty liver disease: A main driver of insulin resistance or dangerous liaison? Biochim biophys acta 1842, 2329-2343 (2014).
3. Lo, L. et al. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol 55, 435-444 (2011).
4. Bechmann, L. P. et al. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56, 952-964 (2012).
5. Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413-1419 (1999).
6. Colman, R. J. et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201-204 (2009).
7. Koubova, J. & Guarente, L. How does calorie restriction work? Genes Dev 17, 313-321 (2003).
8. Hebert, A. S. et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol cell 10, 186-199 (2013).
9. Anderson, R. M. & Weindruch, R. Metabolic reprogramming, caloric restriction and aging. Trends Endocrinol Metab 21, 134-140 (2010).
10. Sunny, N. E., Parks, E. J., Browning, J. D. & Burgess, S. C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14, 804-810 (2011).
11. Westerbacka, J. et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56, 2759-2765 (2007).
12. Schröder, T. et al. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced nonalcoholic steatohepatitis. Mol Metab. 5, 283-295 (2016).
13. Tarantino, G., Savastano, S. & Colao, A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 16, 4773-4783 (2010).
14. Jové, M. et al. Caloric restriction reveals a metabolomic and lipidomic signature in liver of male mice. Aging Cell 13, 828-837 (2014).
15. Hagopian, K., Ramsey, J. J. & Weindruch, R. Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver. Exp Gerontol 38, 267-278 (2003).
16. Laffel, L. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15, 412-426 (1999).
17. Hai-jun, Xu. Role of lactate in lipid metabolism, just always inhibiting lipolysis? J Biol Chem 284, 5 (2009).
18. Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R. & Turner, N. D. Glutathione metabolism and its implications for health. J Nutr 134, 489-492 (2004).
19. Postic, C. & Girard, J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118, 829-838 (2008).
20. Kersten, S. et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103, 1489-1498 (1999).
21. Shimazu, T. et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell metab 12, 654-661 (2010).
22. Hugo, S. E. et al. A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev 26, 282-293 (2012).
23. Begriche, K., Igoudjil, A., Pessayre, D. & Fromenty, B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6, 1-28 (2006).
24. Asimakopoulou, A. et al. Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver. Biochim Biophys Acta 1842, 1513-1524 (2014).
25. Li, J. et al. Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. J Hepatol 56, 900-907 (2012).
26. Fabbrini, E., Sullivan, S. & Klein, S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 51, 679-689 (2010).
27. Fatiha, N. & Ibdah, J. A. Role of Mitochondria in Nonalcoholic Fatty Liver Disease. Int J Mol Sci 15, 8713-8742 (2014).
28. Rashid, A. et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29, 1131-1138 (1999).
29. Walker, A. K. et al. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 24, 1403-1417 (2010).
30. Rajat Singh, S. K. et al. Autophagy regulates lipid metabolism. Nature 458, 1131-1135 (2009).
31. Liu, H. Y. et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem 284, 31484-31492 (2009).
32. Yang, L., Li, P., Fu, S., Calay, E. S. & Hotamisligil, G. S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell metab 11, 467-478 (2010).
33. Chen, G., Liang, G., Ou, J., Goldstein, J. L. & Brown, M. S. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA 101, 11245-11250 (2004).
34. Dentin, R. et al. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 115, 2843-2854 (2005).
35. Coleman, D. L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14, 141-148 (1978).
36. Braissant, O., Foufelle, F., Scotto, C., Dauça, M. & Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354-366 (1996).
37. Oosterveer, M. H. et al. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. J Biol Chem 284, 34036-34044 (2009).
38. Asayama, K. et al. peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptoralpha in diabetic rat liver. Mol Cell Biochem 194, 227-234 (1999).
39. Memon, R. A. et al. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141, 4021-4031 (2000).
40. Shi, T., Wang, F., Stieren, E. & Tong, Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 280, 13560-13567 (2005).
41. Hirschey, M. D. et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125 (2010).
42. Shimazu, T. et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 12, 654-661 (2010).
43. Wei, Y., Rector, S. R., Thyfault, J. P. & Ibdah, J. A. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 14, 193-199 (2008).
44. Bailey, C. J. On the physiology and biochemistry of obesity. Sci Prog 65, 365-393 (1978).
45. Baffy, G., Zhang, C. Y., Glickman, J. N. & Lowell, B. B. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 35, 753-761 (2002).
46. Neuschwander-Tetri, B. A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788 (2010).
47. Tsutsumi, A. et al. Caloric restriction decreases ER stress in liver and adipose tissue in ob/ob mice. Biochem Biophys Res Commun 404, 339-344 (2011).
48. Wellen, K. E. & Hotamisligil, G. S. Inflammation, stress, and diabetes. J Clin Invest 115, 1111-1119 (2005).
49. Kidd, P. M. Phosphatidylcholne: A superior protectant against liver damage. Alternative medicien review 1, 258-274 (1996).
50. Mercier, J. C. & Dinh-Xuan, A. T. Neutralizing ceramide: A major breakthrough or yet another marginal target for the treatment of acute lung injury? Pediatr Res 57, 319-321 (2005).
51. Wang, Y. et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53, 34-41 (2007).
52. Zhang, J. et al. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22, 1416-1426 (2008).
53. Borkham-Kamphorst, E., Drews, F. & Weiskirchen, R. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κ B activation. Liver Int 31, 656-665 (2011).
54. Andrews, N. C. & Faller, D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19, 2499 (1991).
55. Anders S. Analysing RNA-Seg data with DESeq package. Molecular biology 43, 1-17 (2010).